PLG |
PLG: Plasminogen precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
137.000 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
137.000 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
137.000 |
Evidence |
|
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
137.000 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
137.000 |
Evidence |
|
HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
137.000 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
137.000 |
Evidence |
|
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
137.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
137.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
137.000 |
Evidence |
|
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
137.000 |
Evidence |
O
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
137.000 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
RELB |
RELB: Transcription factor RelB |
137.000 |
Evidence |
O
|
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
F5 |
F5: Coagulation factor V precursor |
136.000 |
Evidence |
|
LSM1 |
LSM1, CASM: U6 snRNA-associated Sm-like protein LSm1 |
SNRPF |
SNRPF, PBSCF: Small nuclear ribonucleoprotein F |
136.000 |
Evidence |
|
CDC37 |
CDC37: Hsp90 co-chaperone Cdc37 |
HSP90AA1 |
Hsp89-alpha-delta-N |
136.000 |
Evidence |
O
|
PLD2 |
PLD2: Phospholipase D2 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
136.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
135.000 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
135.000 |
Evidence |
|
FGFR3 |
FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
135.000 |
Evidence |
|
AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
135.000 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
135.000 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
135.000 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
135.000 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
135.000 |
Evidence |
|